|Still have KS on HAART
Nov 12, 2003
I have KS and was diagnosed in August 2001, and shortly thereafter was tested for HIV and was positive. My T-cells are in the 600s and I have been undetectable since Sept. 2001. My KS are on my right ankle. About every 9 months I get a new, but small lesion in the same right ankle area. In particular, will my HAART meds stop the progression of KS, and if so, what is the medication should be taking? I.e. should I change my meds? I am taking Combivir and Viramune and I am undetectable. My meds obviously haven't stopped the progression of my KS, although it is confined to one area on the right ankle and hasn't progressed a lot for 2 years now. However, I am worried about a suspicious small, slightly raised area on my right knee and will be going to the doctor soon to see what that is all about and if it is a KS lesion.
| Response from Dr. Conway
Kaposi's sarcoma is one of those conditions that can occur at any CD4 cell count. It is hard to know whether the HAART regimen you are taking is having an effect on your KS, as we could argue that if you were not on HAART, the lesions would be much worse. It is very encouraging that they are not progressing, and I see no reason to change your treatment regimen. In some settings, I have seen such single lesions treated with radiotherapy with good success. As long as the person remained on HAART, the lesions did not come back and no new ones developed.
Get Email Notifications When This Forum Updates or Subscribe With RSS
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.